Overexpression of RAD51 is a predictor of a poor outcome in colorectal adenocarcinoma [28], breast cancer [29], pancreatic cancer [30] and non-small cell lung cancer [31]. The gene discussed is RAD51; the disease is familial pancreatic carcinoma.